JP3052131U - Stick packaging bag with combination of bifidobacteria and oligosaccharide - Google Patents
Stick packaging bag with combination of bifidobacteria and oligosaccharideInfo
- Publication number
- JP3052131U JP3052131U JP1998002359U JP235998U JP3052131U JP 3052131 U JP3052131 U JP 3052131U JP 1998002359 U JP1998002359 U JP 1998002359U JP 235998 U JP235998 U JP 235998U JP 3052131 U JP3052131 U JP 3052131U
- Authority
- JP
- Japan
- Prior art keywords
- bifidobacteria
- oligosaccharides
- oligosaccharide
- packaging bag
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
(57)【要約】 (修正有)
【課題】ビフィズス菌とオリゴ糖を容易に同時摂取可能
な製品の提供。
【解決手段】油脂コーティングしたビフィズス菌末1と
粉末或は顆粒状のオリゴ糖2とを混合してスティック状
の包装袋3に内包した製品。
(57) [Summary] (Modified) [Problem] To provide a product that can easily ingest bifidobacteria and oligosaccharides simultaneously. SOLUTION: This product is obtained by mixing an oil- and fat-coated bifidobacterium powder 1 and a powdered or granular oligosaccharide 2 and enclosing them in a stick-shaped packaging bag 3.
Description
【0001】[0001]
本考案は、人間が長い間食べてきたタマネギ、ゴボウ、バナナ、蜂蜜、タケノ コ、大豆、甘藷、澱粉、牛乳など天然界にも存在しているオリゴ糖の顆粒または 粉末と油脂コーティングビフィズス菌末との組合せの妙にあります。ひ弱なビフ ィズス菌を出来るかぎり腸まで辿り着かせるために、油脂でやさしく包み込むよ うにします。腸内にやっと辿り着いたひ弱なビフィズス菌を、腸内の有害細菌( 大腸菌・ウエルシュ菌等)の繁殖している厳しい環境に負けないように増殖させ るためには、各種機能を有するオリゴ糖をいっしょに摂取することが大切です。 各種機能を有するオリゴ糖は、ビフィズス菌だけの餌になり、有害細菌(大腸菌 ・ウエルシュ菌等)の餌にはなりません。ビフィズス菌の餌としてオリゴ糖を摂 取することで、厳しい腸内環境の中で棲息することができるようになります。 ビフィズス菌とオリゴ糖だけをひとつの袋に包み込み、いっしょに摂取するこ とで、ビフィズス菌と餌(オリゴ糖)の関係による腸内細菌のバランスを保ち、 人間の健康維持及び増進させることを目的としております。 The present invention is based on oligosaccharide granules or powders that have been eaten by humans for a long time, such as onions, burdock, bananas, honey, bamboo shoots, soybeans, sweet potatoes, starch, and milk. There is strangely the combination with. In order to get the weak bifidobacteria as far as possible to the intestines, wrap them gently in fat. Oligosaccharides with various functions are needed to grow weak bifidobacteria that have finally reached the intestine so that they can survive in the harsh environment where harmful bacteria (such as Escherichia coli and Welsh bacteria) are growing in the intestine. It is important to take together. Oligosaccharides with various functions can only be eaten by bifidobacteria, not by harmful bacteria (such as Escherichia coli and Welsh bacteria). Ingesting oligosaccharides as feed for bifidobacteria enables them to live in harsh intestinal environments. By wrapping only bifidobacteria and oligosaccharides in a single bag and ingesting them together, the purpose is to maintain the balance of intestinal bacteria due to the relationship between bifidobacteria and diet (oligosaccharides), and to maintain and promote human health We are.
【0002】[0002]
現在、ビフィズス菌とオリゴ糖は、いろいろな食品や飲料水に入れられており ます。クッキー・ウエハース・チョコレート・飴・チューインガム・ヨーグルト ・乳酸菌飲料・アイスクリームなどあらゆるものに入れられて商品化されていま す。 ビフィズス菌末も、油脂コーティングされて、スティック包装袋に内包されて 販売されております。 しかし、消費者は、ビフィズス菌やオリゴ糖の効果を、報道媒体で少しづつ理 解し始めておりますが、どの商品もビフィズス菌とオリゴ糖の関係が消費者に理 解されているようには思えません。ビフィズス菌とオリゴ糖が、直接的な因果関 係を確認できる商品が販売されていないからです。 Currently, bifidobacteria and oligosaccharides are contained in various foods and drinking waters. It has been commercialized in cookies, wafers, chocolates, candy, chewing gum, yogurt, lactic acid bacteria drinks, and ice cream. Bifidobacterium powder is also sold after being coated with oil and fat and enclosed in stick packaging bags. However, consumers have begun to gradually understand the effects of bifidobacteria and oligosaccharides in the media, but as with all products, the relationship between bifidobacteria and oligosaccharides is understood by consumers. I don't think This is because there is no product that can confirm the direct causal relationship between Bifidobacteria and oligosaccharides.
【0003】[0003]
砂糖は優れた甘味料ですが、虫歯や肥満あるいは糖尿病の原因として問題にな っています。砂糖は小腸で分解吸収され、人体のエネルギーとして使われます。 ところがオリゴ糖は、人間の消化酵素では分解されず吸収もされません。ですか ら人間のエネルギーに利用されません。開発当初のオリゴ糖は、砂糖の摂取過多 による弊害を是正するための甘味料として製造され、ビフィズス菌の増殖因子と して利用され始めました。 しかし、最近のオリゴ糖を調査してみると、ビフィズス菌の増殖促進による整 腸作用・非う蝕原性・肥満予防などであったものが、サントリーのキシロオリゴ 糖のミネラル吸収促進(特開平7−67575)、明治乳業の乳酸菌を用いた免 疫賦活剤(特開平7−228536)、武田食品工業のニゲロオリゴ糖の免疫賦 活剤(特開平9−52834)、雪印乳業の新規なオリゴ糖、その製造法及びそ の利用(特開平7−316177)・ビフィズス菌及び乳酸菌増殖促進剤(特開 平7−267866)のように、各社が競ってオリゴ糖の機能効果の高揚に全力 を上げて、特許申請しています。 このようにビフィズス菌の増殖因子であったオリゴ糖が、各種の機能を有する 多機能食品として、今後、成長してゆくことは間違い有りません。このオリゴ糖 の多機能効果を充分発揮させることができるということは、ビフィズス菌がそれ らの効果を発揮しているということです。ビフィズス菌とオリゴ糖が一対になる ことで、相乗効果を齎らすものと考えます。ビフィズス菌とオリゴ糖を同時に摂 取する方法が大切です。 ビフィズス菌とオリゴ糖の同時摂取により、現在問題になっている環境汚染や 細菌感染等に対する予防効果が期待できます。 Sugar is an excellent sweetener, but it is a problem as a cause of tooth decay, obesity or diabetes. Sugar is broken down and absorbed in the small intestine and used as energy for the human body. However, oligosaccharides are not decomposed or absorbed by human digestive enzymes. It is not used for human energy. Oligosaccharides at the beginning of the development were manufactured as sweeteners to correct the adverse effects of excessive sugar intake, and have begun to be used as growth factors for bifidobacteria. However, a recent survey of oligosaccharides showed that the promotion of the growth of bifidobacteria caused intestinal effects, non-cariogenicity, and prevention of obesity. However, Suntory promoted the mineral absorption of xylo-oligosaccharides (Japanese Unexamined Patent Publication No. -67575), an immunostimulant using lactic acid bacteria from Meiji Dairies (JP-A-7-228536), an immunostimulator for Nigerooligosaccharides from Takeda Foods Industries (JP-A-9-52834), a novel oligosaccharide from Snow Brand Milk Industry, Its production method and its use (Japanese Patent Application Laid-open No. Hei 7-316177). As in the case of bifidobacteria and lactic acid bacteria growth promoters (Japanese Patent Application Laid-Open No. Hei 7-267866), each company is competing to make every effort to enhance the functional effects of oligosaccharides. Has applied for a patent. There is no doubt that oligosaccharides, which were growth factors for Bifidobacteria, will continue to grow as multifunctional foods with various functions. The ability to fully demonstrate the multifunctional effects of this oligosaccharide means that Bifidobacteria are exhibiting these effects. It is thought that the synergistic effect is brought about by the combination of Bifidobacterium and oligosaccharide. It is important to take Bifidobacteria and oligosaccharides simultaneously. Simultaneous ingestion of bifidobacteria and oligosaccharides can be expected to have a protective effect against the current problems of environmental pollution and bacterial infection.
【0004】[0004]
ビフィズス菌を胃では溶解せずに、できるだけ腸に到達してから溶解して、内 容成分が吸収されるように油脂コーティングをしました。 まず、ビフィズス菌を培地にて培養し、遠心分離などの方法で菌体を濃縮し、洗 浄の後、再度遠心分離する。得られた濃縮菌体を凍結乾燥保護剤を添加し、凍結 乾燥を行なう。乾燥菌体を粉砕後、澱粉、デキストリンなどで倍散して『ビフィ ズス菌末』を製造する。 このビフィズス菌末と微粉状硬化油脂粉末を高速度で物理的に衝突させ、油脂 微粒子をビフィズス菌末表面で展延膜化させる。本処理はビフィズス菌の死滅を 極力抑えるため粉体を冷却しながら、窒素気流下で行なう。本法は乾式造粒コー ティング法の一種であり、製造中の菌の死滅は殆どない。 オリゴ糖は、各社内容成分が違うため、製造方法も各社独自の製法で生産され ている。各種オリゴ糖の中から、森永のラクチュロースについて説明すると、原 料である乳糖を異性化してラクチュロースが得られる。これを精製して、未反応 の乳糖を濃縮・結晶化させて分離・除去し、ラクチュロースシロップとする。こ のシロップをクロマト精製して高純度化し、濃縮・結晶化・乾燥・粉砕して製造 する。 各社が独自の製法で、粉末或は顆粒状に製造された多機能を有するオリゴ糖を 、目的に合わせて単品或はブレンドして、油脂コーティングビフィズス菌と混ぜ 合わせてスティック状の包装袋に適量を内包する。 Bifidobacteria were not dissolved in the stomach, but were dissolved after reaching the intestine as much as possible, and a fat coating was applied so that their components could be absorbed. First, the Bifidobacterium is cultured in a medium, the cells are concentrated by a method such as centrifugation, washed, and then centrifuged again. A freeze-protecting agent is added to the obtained concentrated cells, and the cells are freeze-dried. After crushing the dried cells, the cells are triturated with starch, dextrin, etc. to produce "Bifidobacterium powder". The bifidobacterium powder and the hardened fine powder of fat and oil are caused to physically collide with each other at a high speed, and the fat and oil fine particles are spread on the surface of the bifidobacterium powder. This treatment is performed under a nitrogen stream while cooling the powder to minimize the killing of bifidobacteria. This method is a kind of dry granulation coating method, and almost no bacteria are killed during the production. Oligosaccharides are produced by each company's own manufacturing method because the content components of each company are different. Morinaga's lactulose is explained from various oligosaccharides, and lactose as a raw material is isomerized to obtain lactulose. This is purified, and the unreacted lactose is concentrated and crystallized to be separated and removed to obtain lactulose syrup. This syrup is purified by chromatography, purified, concentrated, crystallized, dried and pulverized. Multi-functional oligosaccharides manufactured in powder or granules by their own manufacturing methods are used individually or blended according to the purpose, mixed with oil- and fat-coated bifidobacteria, and put in appropriate amounts in stick-shaped packaging bags. Including.
【0005】[0005]
スティック状の包装袋に内包された油脂コーティンクビフィズス菌末と粉末或 は顆粒状のオリゴ糖は、その素材をできるだけ天然、自然な状態に維持し、かつ その新鮮さを保持でき、素材から商品化への加工工程において、添加物や熱・水 ・圧力・空気酸化等の品質劣化要因の少ない商品形態に考慮しなければなりませ ん。これ以外に1日摂取量、体内吸収、食べやすさ、取り扱いやすさ、コスト、 関係法規等の要因も考慮しなければなりません。特に油脂でコーティンクされた ビフィズス菌と粉末或は顆粒状のオリゴ糖の配合には、充分配慮して製品化する 必要があります。 この商品形態に限定したのは、特定成分の安定性保持にこれらの形態がすぐれ ていることが大きな理由である。 The oil-and-fat coated bifidobacterium powder and the powdered or granular oligosaccharides contained in the stick-shaped packaging bag can maintain the material as natural and natural as possible and maintain its freshness. In the process of chemical conversion, it is necessary to consider product forms that have little quality deterioration factors such as additives, heat, water, pressure, and air oxidation. In addition, factors such as daily intake, absorption in the body, ease of eating, ease of handling, cost, and relevant laws and regulations must be considered. In particular, the combination of bifidobacteria coated with oils and fats and powdered or granular oligosaccharides should be considered when commercializing products. The limitation to this product form is a major reason that these forms are superior in maintaining the stability of specific components.
【0006】[0006]
【実施例】 1ビフィズス菌と2オリゴ糖が適切な分量で、包装素材たとえば不織布、紙、 ポリエチレンなどの3スティック状の包装袋のなかに包み込む。1ビフィズス菌 と2オリゴ糖が適量入っている3袋を、その3袋が適正な数量分入る箱を造り、 その中にきちんと納まるようにしまいむ。EXAMPLE 1 One bifidobacteria and two oligosaccharides are wrapped in an appropriate amount in a three-stick packaging bag made of a packaging material such as nonwoven fabric, paper, or polyethylene. 3 bags containing 1 bifidobacteria and 2 oligosaccharides in appropriate amounts are made into a box in which the 3 bags can be placed in an appropriate amount, and they are stored properly.
【0007】[0007]
オリゴ糖の消化管での状況を調べてみると、人間の腸には百種類もの細菌が住 み着いており、百兆個も有るといわれいる。大便の乾燥重量の約一割が細菌の菌 体です。生まれたばかりの乳幼児の腸の細菌のほとんどはビフィズス菌ですが、 しだいに大腸菌、ウエルシュ菌などの細菌が多くなってきます。老人になると大 腸菌やウエルシュ菌などが腸内細菌の多くを占めるようになります。 人間にとって有用な菌としてビフィズス菌や乳酸菌があり、とくにビフィズス 菌は大腸内で有害菌を抑制するなどの働きがあります。ビフィズス菌の代表的な 生理効果は、整腸作用、腸内菌フローラの改善、腸内腐敗産物の抑制、排便性状 の改善、免疫賦活効果、骨強度増強、ビタミンの合成、ミネラル吸収促進などが 挙げられます。 オリゴ糖は、各個人が腸内に保有しているビフィズス菌を、他の菌を押さえて 特異的に増殖させ、腸内菌フローラを改善する特長を有しています。 つまり、ビフィズス菌の餌として利用されることにより、ビフィズス菌と同様 の生理的機能を有する。最近は、オリゴ糖の多機能効果によるミネラル吸収、免 疫賦活も認められ、私達の健康維持・増進に大きく寄与するものであります。 Examining the state of oligosaccharides in the gastrointestinal tract reveals that there are hundreds of bacteria inhabiting the human intestine, and there are hundred trillion. About 10% of the dry weight of stool is bacterial cells. Most of the intestinal bacteria in newborn infants are bifidobacteria, but the number of bacteria such as Escherichia coli and Welsh grows gradually. In older people, enterobacteria and Welsh bacteria dominate intestinal bacteria. Bifidobacteria and lactic acid bacteria are useful bacteria for humans, and in particular, bifidobacteria have a function of suppressing harmful bacteria in the large intestine. Typical physiological effects of bifidobacteria include intestinal regulation, improvement of intestinal flora, suppression of intestinal putrefaction products, improvement of defecation properties, immunostimulatory effect, enhancement of bone strength, synthesis of vitamins, promotion of mineral absorption, etc. No. Oligosaccharides have the property of improving the intestinal microflora by allowing individual individuals to grow bifidobacteria in the intestine more specifically than other bacteria. That is, when used as a feed for bifidobacteria, it has the same physiological function as bifidobacteria. In recent years, the absorption of minerals and the activation of immunity due to the multifunctional effects of oligosaccharides have been recognized, which greatly contributes to the maintenance and promotion of our health.
【図1】油脂コーティングされたビフィズス菌と粉末或
は顆粒状のオリゴ糖が内包されたスティック状の包装袋
の一部切欠斜視図。FIG. 1 is a partially cutaway perspective view of a stick-like packaging bag containing oil- and fat-coated bifidobacteria and powdered or granular oligosaccharides.
1.油脂コーティングビフィズス菌。 2.粉末或は顆粒状のオリゴ糖。 3.スティック状の包装袋。 1. Oil-coated bifidobacteria. 2. Powdered or granular oligosaccharides. 3. Stick-shaped packaging bag.
Claims (1)
能を有したオリゴ糖を混ぜ合わせて内包したスティック
包装袋。1. A stick packaging bag in which oil-coated bifidobacterium powder and oligosaccharides having various functions are mixed and included.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1998002359U JP3052131U (en) | 1998-03-10 | 1998-03-10 | Stick packaging bag with combination of bifidobacteria and oligosaccharide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1998002359U JP3052131U (en) | 1998-03-10 | 1998-03-10 | Stick packaging bag with combination of bifidobacteria and oligosaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
JP3052131U true JP3052131U (en) | 1998-09-14 |
Family
ID=43186258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1998002359U Expired - Lifetime JP3052131U (en) | 1998-03-10 | 1998-03-10 | Stick packaging bag with combination of bifidobacteria and oligosaccharide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3052131U (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015198638A (en) * | 2014-03-31 | 2015-11-12 | サンスター株式会社 | Bifidobacteria fermentation method and proliferation method |
US9446111B2 (en) | 2009-04-29 | 2016-09-20 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
US11235008B2 (en) | 2011-03-31 | 2022-02-01 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
-
1998
- 1998-03-10 JP JP1998002359U patent/JP3052131U/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9446111B2 (en) | 2009-04-29 | 2016-09-20 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
US9757442B2 (en) | 2009-04-29 | 2017-09-12 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
US11235008B2 (en) | 2011-03-31 | 2022-02-01 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
US11351206B2 (en) | 2011-03-31 | 2022-06-07 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
JP2015198638A (en) * | 2014-03-31 | 2015-11-12 | サンスター株式会社 | Bifidobacteria fermentation method and proliferation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1255449B1 (en) | Nutritional formulation containing prebiotic substances | |
RU2445361C2 (en) | Prevention and treatment of otitis with using nonpathogenic bacterial strains | |
US20120015075A1 (en) | Chewable supplement with live microorganisms | |
US10925906B2 (en) | Composition for improving brain function for neonates | |
CN102511714A (en) | High-activity probiotic composition suitable for infants and preparation method thereof | |
US5849324A (en) | Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans | |
WO2017069163A1 (en) | Infection preventive agent for infants | |
JP2000232864A (en) | Food containing young barley leaf powder | |
JP2018177703A (en) | Toll-like receptor 2 activating composition | |
CA2532473C (en) | Amino acid supplementation for a healthy microbiota ecosystem | |
JP3052131U (en) | Stick packaging bag with combination of bifidobacteria and oligosaccharide | |
WO2018126310A1 (en) | Isomalto-oligosaccharide prebiotic formulations | |
CN109803668B (en) | Composition for inhibiting the reduction of Lactobacillus in the intestinal tract | |
US10448661B2 (en) | Dry food composition | |
JP4351815B2 (en) | Diet food | |
JP3789146B2 (en) | Oligosaccharide-containing nutritional composition | |
JP3051021U (en) | Health promotion agent by combination of Bifidobacterium and certain oligosaccharides | |
JP2000026304A (en) | Improvement in capacity for locomotion with bifidus bacterium | |
JP2004236589A (en) | Peptide milk | |
EP1254664A2 (en) | Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans | |
JPH1175772A (en) | Addition and utilization of certain kind of oligosaccharide for nutrient or healthy food | |
RU2096974C1 (en) | Method for correcting carbohydrate compound of food products of general and special purpose (versions) | |
KR20220135520A (en) | Packing material for enhancing pill intake of pets | |
JP3124522U (en) | Food composition | |
JP2003113087A (en) | Oligosaccharide-containing nutrient composition |